DUSP9 is upregulated in colorectal cancer with an association with worse DFS [60], it promotes cell proliferation and tumor growth in human HCC cells [61], and its upregulation in triple-negative breast cancer cells correlates with enhanced stemness [62]. This evidence concerns the gene DUSP9 and triple-negative breast carcinoma.